Gonadotrophin-releasing hormone (GnRH) is an important factor in the regulation of the synthesis and secretion of gonadotrophins from the pituitary gland. An isoform of this decapeptide, GnRH-II, with an amino acid sequence 70% homologous to GnRH-I, has been recently described. Since the physiological effects of GnRH-II are not yet known, we undertook the present study to see whether GnRH-II could be involved in the secretion and synthesis of HCG in first trimester trophoblast. We incubated cytotrophoblastic cells (CTB) with GnRH-I or GnRH-II, for 4 or 96 h and collected the media at different times thereafter. We also performed experiments with placental tissue, where GnRH-I or GnRH-II was added to perifused placental explants, and samples were collected every 3 min. Total amounts of human chorionic gonadotrophin (HCG) were measured in all samples by enzyme-linked immunosorbent assay. GnRH-I was more potent than GnRH-II when incubated for 4 h with CTB, as indicated by increased HCG secretion at 8 h and at 24 h. GnRH-I, but not GnRH-II, down-regulated HCG secretion when incubated for 96 h. GnRH-I significantly increased HCG secretion by the explants, while GnRH-II had a lesser effect. Both induced a pulse of HCG immediately after their injection. Our data show that GnRH-I has more effect than GnRH-II on HCG synthesis and secretion. This difference could be explained by different pathways of GnRH degradation, different receptor affinities, or even by different types of placental GnRH receptor.
Introduction
described in several extrapituitary organs, e.g. ovary, testis and placenta (Popkin et al., 1983) . The presence and production The placenta is a unique endocrine organ which secretes, of this decapeptide has also been documented outside the among other hormones, human chorionic gonadotrophin (HCG) hypothalamus (Siler-Khodr and Khodr, 1979) , in the placenta, (Boadi et al., 1992) . HCG is a prime marker of trophoblast where it was thought to exert a paracrine/autocrine action (Canfield et al., 1973) and its secretion is episodic in pregnancy through specific receptors located on the membrane of (Owens et al., 1981; Padmanabhan et al., 1989) . Two types syncytiotrophoblastic cells (Belisle et al., 1984 ; Barnea of HCG pulsatility have been described: long-term, occurring et al., 1991a) . every few hours and short-term, lasting Ͻ1 h. Different studies In addition to hypothalamic GnRH (GnRH-I), a second have shown that HCG secretion is also pulsatile in superfused GnRH form [His5, Trp7, Tyr8] has been described (Chen first trimester placental explants (Owens et al., 1981; Barnea et al., 1998; Gestrin et al., 1999) . Its amino acid sequence is and Kaplan, 1989) .
70% identical to that of GnRH-I (Urbanski et al., 1999) . A The factors which regulate the spontaneous pulsatility of gene encoding GnRH-II is located on the human chromosome HCG are not known, but it has been shown that the episodic 20p13 (White et al., 1998) , distinct from the GnRH-I gene pattern of secretion requires cell-cell contact or communication which is located on chromosome 8p21-p11.2. However, in (Barnea et al., 1992) . Secretion of HCG is stimulated by contrast to GnRH-I, GnRH-II is expressed at significantly gonadotrophin-releasing hormone (GnRH), a decapeptide purihigher levels (up to 30ϫ) outside the brain (White et al., fied in the early 1970s (Nekda et al., 1982) . GnRH is defined 1998), particularly in the kidney, bone marrow, and prostate. as the primary regulator of LH and FSH. The hypothalamic
The presence of a third isoform of GnRH, GnRH-III, in the GnRH secretion is also pulsatile, and it travels via the portal brain of mammals has recently been reported (Yaholom et al., circulation to the pituitary (Pohl et al., 1984) where it acts through specific receptors. Receptors for GnRH have also been 1999). Furthermore, two different types of GnRH receptor enzyme-linked immunosorbent assay (ELISA, Kryptor; CisBio Interhave also been detected in the goldfish brain and pituitary.
national, Saclay, France). In the experiments using CTB, the daily Although these receptors share 71% identity, there are marked production of HCG was calculated according to the following formula:
differences in their ligand selectivity (Illing et al., 1999 
Statistical analysis

Materials and methods
In order to normalize the distribution, statistical evaluation was A total of 32 placentae were obtained by elective pregnancy terminaperformed on log-transformed values, using the Statview Programme tions, carried out in the first trimester (6-11 weeks, legal abortions).
(Abascus) in a personal computer. Tests included one-way analysis of variance (ANOVA), descriptive statistics, paired Student's t-test Preparation and culture of cytotrophoblastic cells (CTB) and correlation analysis when appropriated. P Ͻ 0.05 was considered CTB were prepared according to an already published protocol to be statistically significant. All results were expressed as mean (Bischof et al., 1991) . Briefly, first-trimester trophoblasts, obtained Ϯ SEM. by legal abortions, were dissected out and rinsed to remove the blood.
For the superfusion experiments, we calculated the area under the The tissue was minced and digested four times with trypsin and curve (AUC) and the amplitude of HCG pulses. These parameters layered onto a discontinuous Percoll gradient. After centrifugation, were expressed according to the explants weight. AUC was calculated the layer of CTBs was aspirated and the cells immunopurified using according to the following formula: an antibody to CD45 (Dako, Glostrup, Denmark) to eliminate the [Σ(HCG 1 -HCG 2 )/2ϫ(t 2 -t 1 )] n contaminating leukocytes.
weight Experiment 1 CTB (5ϫ10 5 / well) were incubated in duplicate in serum-free where HCG 1 is the HCG value of the first point of a given pulse; Dulbecco's modified Eagle's medium (DMEM; Gibco, Basel HCG 2 is the HCG value of the next point (after 3 min); t 2 -t 1 is the Switzerland), containing penicillin (100 IU/ml), streptomycin time interval between these two points; and n is the number of pulses. (100 µg/ml), gentamycin (100 µg/ml) and fungison (2.5 µg/ml), for 96 h with or without varying concentrations (10 -12 to 10 -6 mol/l)
Results
of GnRH-I or GnRH-II (a generous gift from Ferring, Zürich, Switzerland). Media were changed on day 2 and 4 and the cultures The data shown in Figure 1 indicate that when CTBs protocol was used, except that GnRH-I or GnRH-II were incubated were incubated for 96 h with GnRH-I or GnRH-II, GnRH-I for only 4 h and the media harvested at 4, 8 and 24 h. Cultures were significantly (P ϭ 0.046 to P ϭ 0.002) down-regulated stopped at 24 h. HCG secretion over four different concentrations. In contrast,
Effect of GnRH-I or GnRH-II on HCG secretion from CTB
Preparation of placental explants and superfusion culture
GnRH-II had no effect on HCG secretion under these con-A superfusion apparatus, consisting of a peristaltic pump driving ditions.
culture medium through a thermostatic (37°C) cell culture chamber When GnRH-I or GnRH-II were incubated for 4 h with to a fraction collector, was used to study the dynamics of HCG CTBs, a significant (P ϭ 0.021 to P Ͻ 0.0001) and dosesecretion. Placental explants of 250-300 mg wet weight were dependent increase of HCG values was observed for GnRH-I dissected out from abortion products, placed in a large excess of and GnRH-II at 8 h (Figure 2 ). GnRH-I was more potent than sterile 0.9% NaCl solution to remove all blood elements and GnRH-II, since a significant (P ϭ 0.021) increase of HCG finally rinsed in antibiotic solution (penicillin 200 IU/ml and streptowas observed with 10 -8 mol/l of GnRH-I, whereas HCG mycin 200 µg/ml). Subsequently, tissues were placed into the culture increased significantly (P ϭ 0.003) only with 10 -7 mol/l of chambers of the superfusion apparatus and eluted with pre-gassed GnRH-II (Figure 2) . When measured at 24 h, HCG was (5% CO 2 in air) HEPES-buffered DMEM (with the components as described for DMEM preparation above). After collecting fractions significantly (P ϭ 0.024, P ϭ 0.046) increased by GnRH-I
(1 ml) of medium every 3 min for 120 min, a pulse (10 -7 and 10 -6 mol/l respectively), whereas GnRH-II had no pulse of HCG after their injection into the system (Figures 4 fashion, even when separated from uterus, and that this secretion is stimulated by GnRH in vivo (Iwashita et al., 1993) and 5). However, the mean amplitude of all pulses was not and in vitro (Siler-Khodr, 1987 ; Currie and Leung, 1993; Li changed either by GnRH-I, or by GnRH-II (results not et al., 1994; Leung and Peng, 1996) . shown). The results from Table I indicate that GnRH-I induced The spontaneous HCG secretion by placental explants is a significant (P ϭ 0.010) increase in the AUC, when compared pulsatile, and this is enabled by cell-cell contact or communicawith controls (media without GnRH-I). In contrast, GnRH-II tion, as shown previously (Barnea et al., 1992) . The lack of had no effect on the AUC (Table I ). The pulse frequency was pulsatility in isolated cells demonstrates that it requires the significantly (P ϭ 0.008, P ϭ 0.02) decreased by both GnRH-I functional integrity of the tissue, where both cyto-and and II (Table I) .
syncytiotrophoblast elements appear to have an important role. Indeed, it has been suggested that the cytotrophoblast
Discussion
secretes GnRH-I, while the syncytiotrophoblast secretes HCG It has been well established that most hormonal secretions are (Barnea et al., 1992) . However, the presence of GnRH-II in episodic, when followed in the peripheral circulation with an the placenta has not yet been reported. appropriate time of sampling. Recent studies have observed
Our results are in line with previous observations and show that HCG release by first trimester placental explants is that the placenta continues to secrete HCG in a pulsatile pulsatile, and that this episodic secretion is enhanced by frequency and amplitude after GnRH treatment. These different results can probably be explained by the diverse protocols GnRH. The spontaneous HCG pulses (in absence of exogenous GnRH) had a similar amplitude, with a mean frequency of used. In our experiments, we added GnRH only once to first trimester placental explants, while in the other authors' every 30.5 min. After GnRH treatment, the mean frequency was about every 39 min for both forms of GnRH. Thus both protocol, GnRH was added several times at different intervals (range 30-72 min). GnRH-I and GnRH-II caused a decrease in HCG pulse frequency from placental explants. The amplitude of the HCG In our experiments with placental explants, we observed a rapid effect of GnRH on HCG secretion. This rapid effect pulses was not changed by either form of GnRH, whereas only GnRH-I induced an increase in the AUC. In previous resembles that seen in the pituitary (Loumaye and Catt, 1983) and could be independent of receptors (cell depolarization), studies (Barnea and Kaplan, 1989; Barnea et al., 1991a,b) , a similar increase in AUC has been observed. In contrast to since it is observed within 6 min after GnRH administration. The immediate peak after GnRH treatment is unique in its our data, these authors have described an increase of pulse HCG ϭ human chorionic gonadotrophin; GnRH ϭ gonadotrophin-releasing hormone. *Significantly different (P ϭ 0.02), compared with medium alone (GnRH-0). **Significantly different (P ϭ 0.008), compared with medium alone (GnRH-0). ***Significantly different (P ϭ 0.01), compared with medium alone (GnRH-0).
amplitude, and almost similar in amplitude for both forms et al., 1997; Lescheid et al., 1997; Quanbeck et al., 1997) , including humans (White et al., 1998) , and cows (Duello and of GnRH.
Previous studies have shown that placental tissue restores Boyle, 1997). Furthermore, other GnRH-like factors are present in human reproductive tissues (Li et al., 1987) , and postits ability to store HCG within a short time and specific HCG storage granules appear in first trimester placenta, but not in translationally modified forms of GnRH are active in the human placenta (Gautron et al., 1981 (Gautron et al., , 1992 Currie et al., 1993) . term placentae (Morrish et al., 1987) . This could suggest that the granules are needed for the pulsatile HCG secretion. This Both authentic GnRH forms (Osathanondh and Elkind-Hirsch, 1981; Tan and Rousseau, 1982; Zhuang et al., 1991 ; Raga pulsatility would reflect the release of granules, which pass from the synthesis/storage phase to that of release (Yen, 1986 (Yen, ). et al., 1999 and larger GnRH-like peptides (Mathialagan and Rao, 1986a,b; Zhuang et al, 1991) , have been reported to be The factors responsible for this seem to be paracrine, and GnRH is a likely candidate. present in human placental tissues. Our results provide evidence for different effects of the two Although our study may suggest a rapid receptor-independent secretion of HCG, the effect of GnRH on HCG secretion GnRH isoforms (GnRH-I and GnRH-II) on HCG secretion and synthesis, in both CTB and placental explants. In explant has also been shown to last for 30 min, suggesting that GnRH binds locally to produce a prolonged effect (Barnea et al., experiments, GnRH-I caused an increase in the AUC of HCG pulses, while GnRH-II did not. Other parameters, e.g. mean 1991a). Furthermore, a rapid, receptor-independent effect has so far only been reported for steroids, including progesterone frequency of pulses and their amplitude, were very similar for both forms of GnRH. We would speculate that GnRH-I induces (Barnea et al., 1991b) .
In our hands, GnRH-I seems to be more effective than both HCG secretion and synthesis in CTB, thus behaving as a placental GnRH, whereas GnRH-II induces HCG secretion, GnRH-II. It is well-known that most species express more than one isoform of GnRH (Sherwood et al., 1993; King and but not its synthesis. This speculation remains to be investigated using reverse transcription-polymerase chain reaction (RTMillar, 1995 
